The World Health Organization has issued new guidelines supporting the use of Ozempic-type drugs for long-term obesity treatment, highlighting their effectiveness but also raising concerns about affordability, side effects, and global access.
Stacked weekly counts; colour by editorial lean. Stuff and The Spinoff lean centre-left, NZ Herald centre-right, others centre.
How press outlets have named this topic, week by week.
Most recent 2 articles linking to this topic.
Up to 12 framings spread across outlets. Each framing is the LLM's one-line characterisation of the article's editorial angle — not a quote.
high cost limits access despite medical benefits
Ozempic type drugs backed by who for treating obesityparents face financial burden of overseas treatment
Family faces overseas treatment costs after Queenstown boy’s neuroblastoma returnsSocial-media signal on the same topic, drawn from the social lens. Engagement is likes + 2×shares + 3×replies, the same weighting used across the digest cards. View on /social →
Spotted something wrong on this page? Report a correction.